ASP-502D

N/A

Report date: 2025/01/26 17:28:30
NME

Base Information

Drug NameASP-502D
Drug Alias Namereceptor tyrosine kinase inhibitor (Ascepion)ASP-502D
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNerve growth factor receptor Trk-A degraders
TargetsNerve growth factor receptor Trk-A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAscepion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAscepion Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A